Abstract: Some suggest using immunity certification as a path to return to some sense of normalcy during the current pandemic. Despite unclear science, companies are racing ahead with the creation of digital immunity tools. What are the risks? Will a divide between the “immunity haves” and “have nots” be created in this domain? Is this an ethical way forward?
Sponsored by The Hastings Center